Wipro LimitedNSE: WIPRO

Press Release May 05 2021

· Issued by Wipro Limited

Filed with NSE · · 3 pages · English

Summary by 6ix AI

Wipro Limited has issued an updated press release regarding its partnership with Transcell Oncologics to enhance vaccine safety assessment using augmented intelligence. The collaboration aims to improve the safety of global vaccine immunization programs by applying AI to predict adverse effects from vaccinations. This innovative approach replaces traditional animal testing methods and integrates seamlessly into existing workflows in vaccine production. The partnership is expected to lead to safer and more effective vaccines, benefiting researchers and patients alike.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Wipro Limited on 6ix

Earlier from Wipro

Later from Wipro

All Wipro news releases